HIF1A and stroke disorder: HIF-1α stabilization-based intervention in ischemia using inhibitors of its hydroxylating enzyme prolyl hydroxylases (PHDs) has provided neuroprotection and stimulated neurorecovery in a number of preclinical studies [25], indicating that HIF-1α stabilization by GSNO/S-nitrosylation is a logical target for stroke treatment.